Niels Jongs

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 82 publications

Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis.

Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis.

Journal: European heart journal

Published: July 24, 2026

Acute kidney injury-epidemiology in intensive care unit patients 2: study protocol for a prospective international multicentre cohort study.

Acute kidney injury-epidemiology in intensive care unit patients 2: study protocol for a prospective international multicentre cohort study.

Journal: BMJ open

Published: July 09, 2026

Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical Trial.

Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical Trial.

Journal: JAMA

Published: June 05, 2026

Finerenone in Persons with Chronic Kidney Disease without Diabetes.

Finerenone in Persons with Chronic Kidney Disease without Diabetes.

Journal: The New England journal of medicine

Published: June 05, 2026

Efficacy and safety of dapagliflozin in patients receiving dialysis: a post-hoc analysis of the DAPA-CKD trial.

Efficacy and safety of dapagliflozin in patients receiving dialysis: a post-hoc analysis of the DAPA-CKD trial.

Journal: Clinical kidney journal

Published: May 20, 2026

Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY).

Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY).

Journal: Lancet (London, England)

Published: April 23, 2026

Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial.

Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial.

Journal: Diabetes care

Published: April 14, 2026

Finerenone in Type 1 Diabetes and Chronic Kidney Disease.

Finerenone in Type 1 Diabetes and Chronic Kidney Disease.

Journal: The New England journal of medicine

Published: March 04, 2026

New insights from DAPA-CKD indicate dapagliflozin modulates key pathways related to kidney outcomes.

New insights from DAPA-CKD indicate dapagliflozin modulates key pathways related to kidney outcomes.

Journal: Kidney international

Published: January 13, 2026

Effects of Semaglutide on Body Composition and GFR: A Prespecified Analysis of the SMART Trial.

Effects of Semaglutide on Body Composition and GFR: A Prespecified Analysis of the SMART Trial.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: December 22, 2025

A Hierarchical Composite Endpoint for Chronic Kidney Disease Progression in Patients with Focal Segmental Glomerulosclerosis.

A Hierarchical Composite Endpoint for Chronic Kidney Disease Progression in Patients with Focal Segmental Glomerulosclerosis.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: November 24, 2025

Association of Urinary EGF with Kidney Outcomes and Effects of Sodium-Glucose Cotransporter 2 Inhibition.

Association of Urinary EGF with Kidney Outcomes and Effects of Sodium-Glucose Cotransporter 2 Inhibition.

Journal: Journal of the American Society of Nephrology : JASN

Published: November 18, 2025

Showing 1-12 of 82

Last Updated: 09/26/2026